Antineoplastic Agents - Clinical Medicine

Learn antineoplastic agents through a comprehensive 3-hour clinical medicine lecture that builds understanding from foundational cell cycle physiology to modern cancer therapeutics. Begin with cell cycle regulation and how cancer cells bypass normal growth controls through CDK activity and signaling pathways, then explore tumor biology concepts including immune surveillance mechanisms and angiogenesis pathways that tumors exploit for survival and expansion. Master chemotherapy drug classifications including antimetabolites, microtubule inhibitors, topoisomerase inhibitors, antitumor antibiotics, and alkylating agents, understanding how each class disrupts specific cellular processes during division and DNA handling. Progress to targeted and immunotherapy approaches, examining protein kinase inhibitors, monoclonal antibodies, hormonal therapies, and immune checkpoint inhibitors with focus on their mechanisms for blocking growth signaling and immune evasion pathways. Connect theoretical knowledge to clinical practice through mapping of therapeutic agents to major malignancies and common treatment regimens, while mastering essential toxicity profiles and protective agents including leucovorin, mesna, amifostine, and dexrazoxane that frequently appear in clinical scenarios. The lecture combines whiteboard instruction with digital presentations to reinforce key concepts and provide systematic organization strategies for exam preparation.